MUS81 and neoplasm: We found that MK1775 and ICB combination treatment significantly elevated CD8+ T cell infiltration and perforin expression in the MUS81 deficient gastric cancer immune proficient mouse model compared to other groups, indicating increased cytotoxic T cells in the tumor microenvironment.